Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Int J Cancer. 2013 Sep 15;133(6):1271-85. doi: 10.1002/ijc.27828. Epub 2012 Oct 11.
Persistent high-risk human papillomavirus (HR-HPV) infection is the strongest risk factor for high-grade cervical precancer. We performed a systematic review and meta-analysis of HPV persistence patterns worldwide. Medline and ISI Web of Science were searched through January 1, 2010 for articles estimating HPV persistence or duration of detection. Descriptive and meta-regression techniques were used to summarize variability and the influence of study definitions and characteristics on duration and persistence of cervical HPV infections in women. Among 86 studies providing data on over 100,000 women, 73% defined persistence as HPV positivity at a minimum of two time points. Persistence varied notably across studies and was largely mediated by study region and HPV type, with HPV-16, 31, 33 and 52 being most persistent. Weighted median duration of any-HPV detection was 9.8 months. HR-HPV (9.3 months) persisted longer than low-risk HPV (8.4 months), and HPV-16 (12.4 months) persisted longer than HPV-18 (9.8 months). Among populations of HPV-positive women with normal cytology, the median duration of any-HPV detection was 11.5 and HR-HPV detection was 10.9 months. In conclusion, we estimated that approximately half of HPV infections persist past 6 to 12 months. Repeat HPV testing at 12-month intervals could identify women at increased risk of high-grade cervical precancer due to persistent HPV infections.
持续存在高危型人乳头瘤病毒(HR-HPV)感染是宫颈癌前病变的最强危险因素。我们对全球范围内 HPV 持续性模式进行了系统评价和荟萃分析。检索了 Medline 和 ISI Web of Science 数据库,以获取截至 2010 年 1 月 1 日评估 HPV 持续性或检测持续时间的文章。采用描述性和荟萃回归技术来总结变异性以及研究定义和特征对女性宫颈 HPV 感染持续性和持续时间的影响。在提供超过 10 万名女性数据的 86 项研究中,73%的研究将持续性定义为至少两个时间点的 HPV 阳性。研究间的持续性差异显著,主要由研究区域和 HPV 型别介导,HPV-16、31、33 和 52 最为持续。任何 HPV 检测的加权中位数持续时间为 9.8 个月。HR-HPV(9.3 个月)的持续性长于低危型 HPV(8.4 个月),HPV-16(12.4 个月)的持续性长于 HPV-18(9.8 个月)。在细胞学正常的 HPV 阳性女性人群中,任何 HPV 检测的中位持续时间为 11.5 个月,HR-HPV 检测的中位持续时间为 10.9 个月。总之,我们估计大约有一半的 HPV 感染持续存在超过 6-12 个月。间隔 12 个月重复 HPV 检测可识别出因持续性 HPV 感染而处于宫颈癌前病变高风险的女性。